Neuroleptic Drugs Alter the Dopamine Transporter-Mediated Uptake and Release of Dopamine: A Possible Mechanism for Drug-Induced Tardive Dyskinesia

By Lee S.H.   Oh D.Y.   Jung S.C.   Kim Y.M.   Cho H.K.   Koh J.K.   Lee Y.S.  

Pharmacological Research, Vol. 35, Iss. 5, 1997-05 ,pp. : 447-450

Academic Press

Access to resources Recommend Favorite

Inhibition by arachidonic acid and other fatty acids of dopamine uptake at the human dopamine transporter

By Chen N.   Appell M.   Berfield J.L.   Reith M.E.A.  

European Journal of Pharmacology, Vol. 478, Iss. 2, 2003-10 ,pp. : 89-95

Elsevier

Access to resources Recommend Favorite

Dopamine transporters and neuronal injury

By Miller G.W.   Gainetdinov R.R.   Levey A.I.   Caron M.G.  

Trends in Pharmacological Sciences, Vol. 20, Iss. 10, 1999-10 ,pp. : 424-429

Elsevier

Access to resources Recommend Favorite

Nitric oxide scavenger carboxy-PTIO potentiates the inhibition of dopamine uptake by nitric oxide donors

By Cao B.-J.   Reith M.E.A.  

European Journal of Pharmacology, Vol. 448, Iss. 1, 2002-07 ,pp. : 27-30

Elsevier

Access to resources Recommend Favorite

Inhibition of neuronal hypersynchrony in vitro differentiates levetiracetam from classical antiepileptic drugs

By Georg Margineanu D.   Klitgaard H.  

Pharmacological Research, Vol. 42, Iss. 4, 2000-10 ,pp. : 281-285

Academic Press

Access to resources Recommend Favorite